Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |